• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

硫氧还蛋白解毒系统在癌症进展和耐药性中的作用

The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance.

作者信息

Jovanović Mirna, Podolski-Renić Ana, Krasavin Mikhail, Pešić Milica

机构信息

Department of Neurobiology, Institute for Biological Research "Siniša Stanković"- National Institute of Republic of Serbia, University of Belgrade, Belgrade, Serbia.

Organic Chemistry Division, Institute of Chemistry, Saint Petersburg State University, Saint Petersburg, Russia.

出版信息

Front Mol Biosci. 2022 May 19;9:883297. doi: 10.3389/fmolb.2022.883297. eCollection 2022.

DOI:10.3389/fmolb.2022.883297
PMID:35664671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9161637/
Abstract

The intracellular redox homeostasis is a dynamic balancing system between the levels of free radical species and antioxidant enzymes and small molecules at the core of cellular defense mechanisms. The thioredoxin (Trx) system is an important detoxification system regulating the redox milieu. This system is one of the key regulators of cells' proliferative potential as well, through the reduction of key proteins. Increased oxidative stress characterizes highly proliferative, metabolically hyperactive cancer cells, which are forced to mobilize antioxidant enzymes to balance the increase in free radical concentration and prevent irreversible damage and cell death. Components of the Trx system are involved in high-rate proliferation and activation of pro-survival mechanisms in cancer cells, particularly those facing increased oxidative stress. This review addresses the importance of the targetable redox-regulating Trx system in tumor progression, as well as in detoxification and protection of cancer cells from oxidative stress and drug-induced cytotoxicity. It also discusses the cancer cells' counteracting mechanisms to the Trx system inhibition and presents several inhibitors of the Trx system as prospective candidates for cytostatics' adjuvants. This manuscript further emphasizes the importance of developing novel multitarget therapies encompassing the Trx system inhibition to overcome cancer treatment limitations.

摘要

细胞内氧化还原稳态是细胞防御机制核心的自由基种类与抗氧化酶及小分子水平之间的动态平衡系统。硫氧还蛋白(Trx)系统是调节氧化还原环境的重要解毒系统。该系统也是细胞增殖潜能的关键调节因子之一,通过还原关键蛋白发挥作用。氧化应激增加是高度增殖、代谢活跃的癌细胞的特征,这些癌细胞被迫调动抗氧化酶来平衡自由基浓度的增加,防止不可逆转的损伤和细胞死亡。Trx系统的组成部分参与癌细胞的高速增殖和促生存机制的激活,尤其是那些面临氧化应激增加的癌细胞。本综述阐述了可靶向的氧化还原调节Trx系统在肿瘤进展以及癌细胞解毒、免受氧化应激和药物诱导的细胞毒性方面的重要性。还讨论了癌细胞对Trx系统抑制的对抗机制,并介绍了几种Trx系统抑制剂作为细胞抑制剂佐剂的潜在候选药物。本文进一步强调了开发包含Trx系统抑制的新型多靶点疗法以克服癌症治疗局限性的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/629bd1c5f32b/fmolb-09-883297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/ef2b655d077f/fmolb-09-883297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/618fbca6227b/fmolb-09-883297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/629bd1c5f32b/fmolb-09-883297-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/ef2b655d077f/fmolb-09-883297-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/618fbca6227b/fmolb-09-883297-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b26a/9161637/629bd1c5f32b/fmolb-09-883297-g003.jpg

相似文献

1
The Role of the Thioredoxin Detoxification System in Cancer Progression and Resistance.硫氧还蛋白解毒系统在癌症进展和耐药性中的作用
Front Mol Biosci. 2022 May 19;9:883297. doi: 10.3389/fmolb.2022.883297. eCollection 2022.
2
Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications.探索硫氧还蛋白系统作为癌症治疗靶点:机制与意义
Antioxidants (Basel). 2024 Sep 4;13(9):1078. doi: 10.3390/antiox13091078.
3
The thioredoxin antioxidant system.硫氧还蛋白抗氧化系统。
Free Radic Biol Med. 2014 Jan;66:75-87. doi: 10.1016/j.freeradbiomed.2013.07.036. Epub 2013 Jul 27.
4
The Thioredoxin System of Mammalian Cells and Its Modulators.哺乳动物细胞的硫氧还蛋白系统及其调节剂
Biomedicines. 2022 Jul 21;10(7):1757. doi: 10.3390/biomedicines10071757.
5
A thioredoxin reductase and/or thioredoxin system-based mechanism for antioxidant effects of ambroxol.基于硫氧还蛋白还原酶和/或硫氧还蛋白系统的氨溴索抗氧化作用机制。
Biochimie. 2014 Feb;97:92-103. doi: 10.1016/j.biochi.2013.09.024. Epub 2013 Oct 5.
6
The thioredoxin system and cancer therapy: a review.硫氧还蛋白系统与癌症治疗:综述。
Cancer Chemother Pharmacol. 2019 Nov;84(5):925-935. doi: 10.1007/s00280-019-03912-4. Epub 2019 Jul 31.
7
Enzyme-linked immunospot assay for detection of thioredoxin and thioredoxin reductase secretion from cells.用于检测细胞分泌硫氧还蛋白和硫氧还蛋白还原酶的酶联免疫斑点测定法。
Methods Enzymol. 2002;353:22-35. doi: 10.1016/s0076-6879(02)53033-0.
8
Thioredoxin system inhibitors as mediators of apoptosis for cancer therapy.硫氧还蛋白系统抑制剂作为癌症治疗中细胞凋亡的介质
Mol Nutr Food Res. 2009 Jan;53(1):87-103. doi: 10.1002/mnfr.200700492.
9
Thioredoxin system in cell death progression.细胞死亡进程中的硫氧还蛋白系统。
Antioxid Redox Signal. 2012 Dec 15;17(12):1738-47. doi: 10.1089/ars.2012.4650. Epub 2012 Jun 11.
10
Recent advances in the development of thioredoxin reductase inhibitors as anticancer agents.硫氧还蛋白还原酶抑制剂作为抗癌剂的研究进展。
Curr Drug Targets. 2012 Oct;13(11):1432-44. doi: 10.2174/138945012803530224.

引用本文的文献

1
Reactive Oxygen Species: From Tumorigenesis to Therapeutic Strategies in Cancer.活性氧:从肿瘤发生到癌症治疗策略
Cancer Med. 2025 May;14(10):e70947. doi: 10.1002/cam4.70947.
2
Searching for New Gold(I)-Based Complexes as Anticancer and/or Antiviral Agents.寻找新型基于金(I)的配合物作为抗癌和/或抗病毒药物。
Molecules. 2025 Apr 11;30(8):1726. doi: 10.3390/molecules30081726.
3
Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies.金诺芬对硫氧还蛋白还原酶的抑制作用作为胶质母细胞瘤的促氧化抗癌策略:体外和体内研究

本文引用的文献

1
Understanding Cellular Redox Homeostasis: A Challenge for Precision Medicine.理解细胞氧化还原稳态:精准医学的挑战。
Int J Mol Sci. 2021 Dec 22;23(1):106. doi: 10.3390/ijms23010106.
2
Metal- and metalloid-based compounds to target and reverse cancer multidrug resistance.金属和类金属基化合物靶向和逆转癌症多药耐药性。
Drug Resist Updat. 2021 Sep;58:100778. doi: 10.1016/j.drup.2021.100778. Epub 2021 Aug 6.
3
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Int J Mol Sci. 2025 Feb 27;26(5):2084. doi: 10.3390/ijms26052084.
4
Exploring the Thioredoxin System as a Therapeutic Target in Cancer: Mechanisms and Implications.探索硫氧还蛋白系统作为癌症治疗靶点:机制与意义
Antioxidants (Basel). 2024 Sep 4;13(9):1078. doi: 10.3390/antiox13091078.
5
Natural products for enhancing the sensitivity or decreasing the adverse effects of anticancer drugs through regulating the redox balance.通过调节氧化还原平衡来增强抗癌药物敏感性或降低其不良反应的天然产物。
Chin Med. 2024 Aug 20;19(1):110. doi: 10.1186/s13020-024-00982-2.
6
The Cancer Antioxidant Regulation System in Therapeutic Resistance.治疗抗性中的癌症抗氧化调节系统
Antioxidants (Basel). 2024 Jun 27;13(7):778. doi: 10.3390/antiox13070778.
7
Comparison of the Regenerative Metabolic Efficiency of Lipid Extracts from Microalgae and on Fibroblasts.微藻脂质提取物对成纤维细胞的再生代谢效率比较
Antioxidants (Basel). 2024 Feb 24;13(3):276. doi: 10.3390/antiox13030276.
8
Potentiation of Cisplatin Cytotoxicity in Resistant Ovarian Cancer SKOV3/Cisplatin Cells by Quercetin Pre-Treatment.槲皮素预处理增强耐药卵巢癌细胞 SKOV3/顺铂细胞中的顺铂细胞毒性。
Int J Mol Sci. 2023 Jun 30;24(13):10960. doi: 10.3390/ijms241310960.
9
Cancer stem cell fate determination: mito-nuclear communication.肿瘤干细胞命运决定:线粒体-核通讯。
Cell Commun Signal. 2023 Jun 27;21(1):159. doi: 10.1186/s12964-023-01160-x.
10
Oxidative Stress Linking Obesity and Cancer: Is Obesity a 'Radical Trigger' to Cancer?氧化应激与肥胖和癌症的关系:肥胖是否是癌症的“自由基触发因素”?
Int J Mol Sci. 2023 May 8;24(9):8452. doi: 10.3390/ijms24098452.
一项将9种重新利用的药物与替莫唑胺联合用于治疗复发性胶质母细胞瘤的Ib/IIa期试验:CUSP9v3
Neurooncol Adv. 2021 Jun 24;3(1):vdab075. doi: 10.1093/noajnl/vdab075. eCollection 2021 Jan-Dec.
4
Novel TrxR1 Inhibitors Show Potential for Glioma Treatment by Suppressing the Invasion and Sensitizing Glioma Cells to Chemotherapy.新型硫氧还蛋白还原酶1抑制剂通过抑制胶质瘤细胞侵袭和使其对化疗敏感显示出治疗胶质瘤的潜力。
Front Mol Biosci. 2020 Oct 6;7:586146. doi: 10.3389/fmolb.2020.586146. eCollection 2020.
5
Drug repositioning of antiretroviral ritonavir for combinatorial therapy in glioblastoma.抗逆转录病毒药物利托那韦的药物重定位用于胶质母细胞瘤的联合治疗。
Eur J Cancer. 2020 Nov;140:130-139. doi: 10.1016/j.ejca.2020.09.017. Epub 2020 Oct 19.
6
Antiproliferative Properties of a Few Auranofin-Related Gold(I) and Silver(I) Complexes in Leukemia Cells and their Interferences with the Ubiquitin Proteasome System.金诺芬相关金(I)和银(I)配合物对白血病细胞的抗增殖作用及其对泛素蛋白酶体系统的干扰。
Molecules. 2020 Sep 28;25(19):4454. doi: 10.3390/molecules25194454.
7
Oxidative Stress in Cancer.癌症中的氧化应激。
Cancer Cell. 2020 Aug 10;38(2):167-197. doi: 10.1016/j.ccell.2020.06.001. Epub 2020 Jul 9.
8
TXNIP induces growth arrest and enhances ABT263-induced apoptosis in mixed-lineage leukemia-rearranged acute myeloid leukemia cells.TXNIP 诱导混合谱系白血病重排的急性髓系白血病细胞生长停滞并增强 ABT263 诱导的细胞凋亡。
FEBS Open Bio. 2020 Aug;10(8):1532-1541. doi: 10.1002/2211-5463.12908. Epub 2020 Jun 24.
9
Thioredoxin System Protein Expression Is Associated with Poor Clinical Outcome in Adult and Paediatric Gliomas and Medulloblastomas.硫氧还蛋白系统蛋白表达与成人和儿童脑胶质瘤和髓母细胞瘤的不良临床结局相关。
Mol Neurobiol. 2020 Jul;57(7):2889-2901. doi: 10.1007/s12035-020-01928-z. Epub 2020 May 16.
10
Reactive oxygen species (ROS) as pleiotropic physiological signalling agents.活性氧(ROS)作为多效生理信号剂。
Nat Rev Mol Cell Biol. 2020 Jul;21(7):363-383. doi: 10.1038/s41580-020-0230-3. Epub 2020 Mar 30.